Catalent (CTLT)
(Delayed Data from NYSE)
$55.92 USD
+0.12 (0.22%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $55.90 -0.02 (-0.04%) 7:58 PM ET
5-Strong Sell of 5 5
D Value C Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Catalent, Inc. [CTLT]
Reports for Purchase
Showing records 181 - 200 ( 214 total )
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
A Few Thoughts on the Juniper Pharmaceuticals Acquisition
Provider: KEYBANC CAPITAL MARKETS
Analyst: HOOKER D
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Bullish LT Outlook, but Entering Period of Tough Comparisons
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Results Again Exceed Expectations; Comparisons Start Getting Tougher, Though
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Updating Our Model for the Close of Cook Pharmica
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Acquisition Increases Biologics Exposure at a Reasonable Price
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS